Back to Search
Start Over
[Human Papillomavirus: screening of cervical and anal cancers].
- Source :
-
Revue medicale suisse [Rev Med Suisse] 2022 Oct 19; Vol. 18 (800), pp. 1950-1955. - Publication Year :
- 2022
-
Abstract
- Cervical cancer is preventable through primary and secondary prevention. Vaccination against the human papillomavirus (HPV), the virus necessary for the development of precancerous lesions, can prevent most of them. Screening by cytology for these precancerous (or cancerous) lesions can be replaced by screening for certain types of HPV, high risk (HR-HPV), causing cervical cancer. The presence of HR-HPV on the cervix should raise suspicion of concomitant infection in the anus, as both epithelia are highly susceptible. This attitude is dictated by the increase incidence in anal cancer in the population, which is also HPV-dependent and therefore also potentially preventable through vaccination and screening.<br />Competing Interests: La Dre Martine Jacot-Guillarmod est membre du comité consultatif sur la vaccination HPV chez MSD. L’entier des honoraires est reversé au CHUV. Les autres auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.
- Subjects :
- Female
Humans
Papillomaviridae
Cervix Uteri pathology
Early Detection of Cancer
Uterine Cervical Neoplasms diagnosis
Uterine Cervical Neoplasms epidemiology
Uterine Cervical Neoplasms prevention & control
Papillomavirus Infections complications
Papillomavirus Infections diagnosis
Papillomavirus Infections epidemiology
Alphapapillomavirus
Anus Neoplasms diagnosis
Anus Neoplasms epidemiology
Anus Neoplasms prevention & control
Papillomavirus Vaccines
Subjects
Details
- Language :
- French
- ISSN :
- 1660-9379
- Volume :
- 18
- Issue :
- 800
- Database :
- MEDLINE
- Journal :
- Revue medicale suisse
- Publication Type :
- Academic Journal
- Accession number :
- 36259700
- Full Text :
- https://doi.org/10.53738/REVMED.2022.18.800.1950